McGuigan A, Whitworth J, Andreou A, Hearn T; Genomics England Research Consortium, Tischkowitz M, Maher ER. et al. Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update. Eur J Hum Genet. 2022 Jan 4. doi: 10.1038/s41431-021-01013-6. Online ahead of print. PMID: 34983940
Puri C, Rubinsztein DC. TMED9–SEC12, an important “contact” for autophagy. Cell Res. 32, 111–112, 2022. doi: 10.1038/s41422-021-00579-6
Garrett A, Loveday C, King L, Butler S, Robinson R, Horton C, Yussuf A, et al. Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD. Genet Med. 2022 Jan;24(1):41-50. doi: 10.1016/j.gim.2021.08.004. PMID: 34906457 Free PMC article.
Ursprung S, Woitek R, McLean MA, Priest AN, Crispin-Ortuzar M, Brodie CR. Gill AB. et al. Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma—A Proof of Principle Study. Cancers. 2022, 14, 335. https://doi.org/10.3390/cancers14020335
Mellis R, Eberhardt RY, Hamilton SJ, The PAGE Consortium, McMullan DJ, Kilby MD, Maher ER, et al. Fetal exome sequencing for isolated increased nuchal translucency: should we be doing it? BJOG 2022;129:52-60. doi: 10.1111/1471-0528.16869
Lopez A, Fleming A, Rubinsztein DC. Measurement of Neuronal Tau Clearance In Vivo. In: Loos B., Wong E. (eds) vol 171. Humana, New York, NY. 2022. doi: 10.1007/978-1-0716-1589-8_7
Guffanti F, Alvisi MF, Anastasia A, Ricci F, Chiappa M, Llop-Guevara A, Serra V, et al. Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts. Br J Cancer. 2022 Jan;126(1):120-128. doi: 10.1038/s41416-021-01609-1. PMID: 34732853
Fleming A, Bourdenx M, Fujimaki M, Karabiyik C, Krause GJ, Lopez A, Martín-Segura A, et al. The different autophagy degradation pathways and neurodegeneration. Neuron. 2022 Jan 31:S0896-6273(22)00056-3. doi: 10.1016/j.neuron.2022.01.017. Online ahead of print. PMID: 35134347 Review.
Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, Nielsen HR, et al. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. J Clin Oncol. 2022 Jan 25:JCO2102112. doi: 10.1200/JCO.21.02112. Online ahead of print. PMID: 35077220
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 Jan 14. doi: 10.1038/s41431-021-00987-7. Online ahead of print. PMID: 35027648
Grinkevich V, Wappett M, Crawford N, Price S, Lees A, McCann C, McAllister KA, et al. Functional genomic identification of predictors of sensitivity and mechanisms of resistance to multivalent 2nd generation TRAIL-R2 agonists. Mol Cancer Ther. 2022 Jan 27:molcanther.MCT-21-0532-A.2021. doi: 10.1158/1535-7163.MCT-21-0532. Online ahead of print. PMID: 35086954
Melland H, Bumbak F, Kolesnik-Taylor A, Ng-Cordell E, John A, Constantinou P, Joss S, et al. Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder. Genet Med. 2022 Jan 28:S1098-3600(21)05421-6. doi: 10.1016/j.gim.2021.12.002. Online ahead of print. PMID: 35101335
Woodford MR, Andreou A, Baba M, van de Beek I, Di Malta C, Glykofridis I, Grimes H, et al. Seventh BHD international symposium: recent scientific and clinical advancement. Oncotarget. 2022 Jan 20;13:173-181. doi: 10.18632/oncotarget.28176. eCollection 2022. PMID: 35070081 Free PMC article
Hitomi Y, Aiba Y, Ueno K, Nishida N, Kawai Y, Kawashima M, Yasunami M, et al. rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis. J Autoimmun. 2022 Jan;126:102775. doi: 10.1016/j.jaut.2021.102775. Epub 2021 Dec 2. PMID: 34864633
Lee A, Mavaddat N, Cunningham A, Carver T, Archer S, Walter F, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1, updates to tumour pathology and cancer incidences. medRxiv 2022.01.27.22269825. doi: 10.1101/2022.01.27.22269825
Shariq OA, Lines KE, English KA, Jafar-Mohammadi B, Prentice P, Casey R, Challis BG, et al. Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes. Surgery. 2022 Jan;171(1):77-87. doi: 10.1016/j.surg.2021.04.041. Epub 2021 Jun 26. PMID: 34183184
Tamborero D, Dienstmann R, Rachid MH, Boekel J, Lopez-Fernandez A, Jonsson M, Razzak A, et al. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. Nat Cancer. 2022 Feb;3(2):251-261. doi: 10.1038/s43018-022-00332-x. PMID: 35221333
Maher ER, Adlard J, Barwell J, Brady AF, Brennan P, Cook J, Crawford GS, et al. Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service. Br J Cancer. 2022 May;126(9):1339-1345. doi: 10.1038/s41416-022-01724-7. Epub 2022 Feb 19. PMID: 35184155
Ochoa E, Lee S, Lan-Leung B, Dias RP, Ong KK, Radley JA, Pérez de Nanclares G, et al. ImprintSeq, a novel tool to interrogate DNA methylation at human imprinted regions and diagnose multilocus imprinting disturbance. Genet Med. 2022 Feb;24(2):463-474. doi: 10.1016/j.gim.2021.10.011. PMID: 34906518
Thompson AJ, Alwan YM, Ramani VAC, Evans DG, Maher ER, Woodward ER. Cost-effectiveness model of renal cell carcinoma (RCC) surveillance in hereditary leiomyomatosis and renal cell carcinoma (HLRCC). J Med Genet. 2022 Feb 4:jmedgenet-2021-108215. doi: 10.1136/jmedgenet-2021-108215. Online ahead of print. PMID: 35121648
Grimes, H., Holden, S, Babar, J, Karia, S, Wetscherek, M, Barker, A, Herre, J, et al. Combining clinical, radiological and genetic approaches to pneumothorax management. Thorax. 2022;77:196–198. doi:10.1136/thoraxjnl-2021-217210
Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, et al. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572-581]. 2022 Feb;76(2):489. doi: 10.1016/j.jhep.2021.11.015. PMID: 34895949
Charles S, Martin J, Runicles A, Chi Z, Robertson K, Barker ED, Richards C, et al. Rare neurogenetic conditions and mental health of families during COVID-19. 2022/2/1. PsyArXiv 10.31234/osf.io/teb7u
Glasgow C, Lau EYC, Aloj L, Harper I, Cheow H, Das T, Berman L, et al. An approach to a patient with primary hyperparathyroidism and a suspected ectopic parathyroid adenoma. J Clin Endocrinol Metab. 2022 Feb 12:dgac024. doi: 10.1210/clinem/dgac024. Online ahead of print. PMID: 35150267
Benedetta P, Herencia-Ropero A, Llop-Guevara A, Pedretti F, Moles-Fernández A, Viaplana C, Villacampa, G, et al. Preclinical in vivo validation of the RAD51 test for identification of homologous recombination-deficient tumors and patient stratification. Cancer Research. 2022. doi: 10.1158/0008-5472.CAN-21-2409
Fernandez-Estevez M, Wrobel L, Rubinsztein DC. Role of Academia: Drug Repurposing to Induce Autophagy for Treatment of Neurodegenerative Diseases. Royal Society of Chemistry. 2022. 09 Feb 2022. doi: 10.1039/9781839163401
Zheng WQ, Pedersen SV, Thompson K, Bellacchio E, French CE, Munro B, Pearson TS, et al. Elucidating the molecular mechanisms associated with TARS2-related mitochondrial disease. Human Molecular Genetics. 2022 Feb 15;31(4):523-34.
Morton SU, Christodoulou J, Costain G, Muntoni F, Wakeling E, Wojcik MH, French CE, et al. Multicenter Consensus Approach to Evaluation of Neonatal Hypotonia in the Genomic Era: A Review. JAMA Neurology. 2022 Mar 7. doi: 10.1001/jamaneurol.2022.0067. Online ahead of print.
Karamali K, Salau E, Das T, Scoffings D, Casey R, Masterson L, Fish B. 4DCT as first line imaging during Covid pandeminc. British Journal of Surgery, Volume 109, Issue Supplement_2, March 2022, znac057.010, https://doi.org/10.1093/bjs/znac057.010
Natale P, Perrone RD, Tong A, Harris T, Hannan E, Ju A, Burnette E, et al. Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report. Clinical Kidney Journal, Volume 15, Issue 3, March 2022, Pages 407–416, https://doi.org/10.1093/ckj/sfab110
Vergote I, González-Martín A, Ray-Coquard I, Harter P, Colombo N, Pujol P, Lorusso D, et al. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer. Ann Oncol. 2022 Mar;33(3):276-287. doi: 10.1016/j.annonc.2021.11.013. PMID: 34861371
Loong L, Cubuk C, Choi S, Allen S, Torr B, Garrett A, Loveday C, et al. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants. Genet Med. 2022 Mar;24(3):552-563. doi: 10.1016/j.gim.2021.11.011. PMID: 34906453
Pavel M, Tanasa R, Park SJ, Rubinsztein DC. The complexity of biological control systems: An autophagy case study. Bioessays. 2022 Mar;44(3):e2100224. doi: 10.1002/bies.202100224. PMID: 35032045
Hanson H, Durkie M, Lalloo F, Izatt L, McVeigh TP, Cook JA, Brewer C, et al. UK recommendations for SDHA germline genetic testing and surveillance in clinical practice. J Med Genet. 2022 Mar 8:jmedgenet-2021-108355. doi: 10.1136/jmedgenet-2021-108355. Online ahead of print. PMID: 35260474
DiStefano MT, Goehringer S, Babb L, Alkuraya FS, Amberger J, Amin M, et al. The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. medRxiv 2022.01.03.21268593; doi: 10.1101/2022.01.03.21268593
Seed LM and Hearn TJ. A Systematic Review of Utilisation of Diurnal Timing Information in Clinical Trial Design for Long QT Syndrome. Front. Pharmacol. 2022. 13:867131. doi: 10.3389/fphar.2022.867131
Archer S, Fennell N, Colvin E, Laquindanum R, Mills M, Dennis R, Stutzin Donoso F, et al. Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial. Cancers (Basel). 2022 May 31;14(11):2716. doi: 10.3390/cancers14112716. PMID: 35681696
Substitution mutational signatures in whole-genome–sequenced cancers in the UK population. Science. 2022. doi: 10.1126/science.abl9283
Lee S, Ochoa E, Barwick K, Cif L, Rodger F, Docquier F, Pérez-Dueñas B, et al. Comparison of methylation episignatures in KMT2B– and KMT2D-related human disorders. Epigenomics. 2022 May;14(9):537-547. doi: 10.2217/epi-2021-0521. Epub 2022 May 4. PMID: 35506254
Lopez A, Gorb A, Palha N, Fleming A, Rubinsztein DC. A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo. Genes (Basel). 2022 May 12;13(5):868. doi: 10.3390/genes13050868. PMID: 35627253
Yngvadottir B, Andreou A, Bassaganyas L, Larionov A, Cornish AJ, Chubb D, Saunders CN, et al. Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases. Hum Mol Genet. 2022 Apr 20:ddac089. doi: 10.1093/hmg/ddac089. Epub ahead of print. PMID: 35441217
Chen OJ, Castellsagué E, Moustafa-Kamal M, Nadaf J, Rivera B, Fahiminiya S, Wang Y, et al. Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial Cancer. Cancer Res. 2022 Oct 4;82(19):3499-3515. doi: 10.1158/0008-5472.CAN-21-3956. PMID: 35913887
Reid KM, Spaull R, Salian S, Barwick K, Meyer E, Zhen J, Hirata H, et al. MED27, SLC6A7, and MPPE1 Variants in a Complex Neurodevelopmental Disorder with Severe Dystonia. Mov Disord. 2022 Oct;37(10):2139-2146. doi: 10.1002/mds.29147. PMID: 35876425
Majumder P, Edmison D, Rodger C, Patel S, Reid E, Gowrishankar S. AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network. Mol Biol Cell. 2022 Oct 1;33(12):ar102. doi: 10.1091/mbc.E21-09-0473. PMID: 35976706
Wei W, Schon KR, Elgar G, Orioli A, Tanguy M, Giess A, Tischkowitz M, et al. Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes. Nature. 2022 Nov;611(7934):105-114. doi: 10.1038/s41586-022-05288-7. PMID: 36198798
Park SJ, Frake RA, Rubinsztein DC. Increased SORBS3 expression in brain ageing contributes to autophagic decline via YAP1-WWTR1/TAZ signaling. Autophagy. 2022 Jul 12:1-2. doi: 10.1080/15548627.2022.2100106. PMID: 35822241
Wrobel L, Hill SM, Djajadikerta A, Fernandez-Estevez M, Karabiyik C, Ashkenazi A, Barratt VJ, et al. Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance. Nat Commun. 2022 Jul 16;13(1):4146. doi: 10.1038/s41467-022-31905-0. PMID: 35842429
Wrobel L, Hill SM, Rubinsztein DC. SMER28 binding to VCP/p97 enhances both autophagic and proteasomal neurotoxic protein clearance. Autophagy. 2022 Aug 28:1-3. doi: 10.1080/15548627.2022.2116832. PMID: 36036202
Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, Høberg-Vetti H, Haavind MT, et al. Cancer risks by sex and variant type in PTEN Hamartoma Tumor Syndrome. J Natl Cancer Inst. 2022 Sep 28:djac188. doi: 10.1093/jnci/djac188. PMID: 36171661
Allen I, Hassan H, Sofianopoulou E, Eccles D, Turnbull C, Tischkowitz M, Pharoah P, et al. Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis. Br J Cancer. 2022 Nov;127(9):1660-1669. doi: 10.1038/s41416-022-01940-1. PMID: 36115878
Casasent AK, Almekinders MM, Mulder C, Bhattacharjee P, Collyar D, Thompson AM, Jonkers J, et al. Learning to distinguish progressive and non-progressive ductal carcinoma in situ. Nat Rev Cancer. 2022 Oct 19. doi: 10.1038/s41568-022-00512-y. PMID: 36261705
Hakkaart C, Pearson JF, Marquart L, Dennis J, Wiggins GAR, Barnes DR, Robinson BA, et al. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Commun Biol. 2022 Oct 6;5(1):1061. doi: 10.1038/s42003-022-03978-6. PMID: 36203093
Rouhani FJ, Zou X, Danecek P, Badja C, Amarante TD, Koh G, Wu Q, et al. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nat Genet. 2022 Sep;54(9):1406-1416. doi: 10.1038/s41588-022-01147-3. PMID: 35953586
Inglebert M, Dettwiler M, Hahn K, Letko A, Drogemuller C, Doench J, Brown A, et al. A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer. Sci Rep. 2022 Oct 27;12(1):18051. doi: 10.1038/s41598-022-21706-2. PMID: 36302863
Meijer TG, Nguyen L, Van Hoeck A, Sieuwerts AM, Verkaik NS, Ladan MM, Ruigrok-Ritstier K, et al. Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests. Oncogene. 2022 Jun;41(26):3498-3506. doi: 10.1038/s41388-022-02363-1. PMID: 35662281
Giger OT, Ten Hoopen R, Shorthouse D, Abdullahi S, Bulusu VR, Jadhav S, Maher ER, et al. Preferential MGMT hypermethylation in SDH-deficient wild-type GIST. J Clin Pathol. 2022 Oct 5:jcp-2022-208462. doi: 10.1136/jcp-2022-208462. PMID: 36198483
Gee LMV, Barron-Millar B, Leslie J, Richardson C, Zaki MYW, Luli S, Burgoyne RA, et al. Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct Ligated Mice. Am J Pathol. 2022 Oct 13:S0002-9440(22)00312-1. doi: 10.1016/j.ajpath.2022.09.005. PMID: 36243043
Eggermann T, Maher ER, Kratz CP, Prawitt D. Molecular Basis of Beckwith-Wiedemann Syndrome Spectrum with Associated Tumors and Consequences for Clinical Practice. Cancers (Basel). 2022 Jun 23;14(13):3083. doi: 10.3390/cancers14133083. PMID: 35804856
Lips EH, Kumar T, Megalios A, Visser LL, Sheinman M, Fortunato A, Shah V, et al. . Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nat Genet. 2022 Jun;54(6):850-860. Doi: 10.1038/s41588-022-01082-3. PMID: 35681052
Durinikova E, Reilly NM, Buzo K, Mariella E, Chilà R, Lorenzato A, Dias JML, et al. Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer. Clin Cancer Res. 2022 Sep 1;28(17):3874-3889. Doi: 10.1158/1078-0432.CCR-22-0875. PMID: 35881546
Mackay D, Bliek J, Kagami M, Tenorio-Castano J, Pereda A, Brioude F, Netchine I, et al. First step towards a consensus strategy for multi-locus diagnostic testing of imprinting disorders. Clin Epigenetics. 2022 Nov 7;14(1):143. doi: 10.1186/s13148-022-01358-9. PMID: 36345041
Valcarcel-Jimenez L, Rogerson C, Yong C, Schmidt C, Yang M, Cremades-Rodelgo M, Harle V, et al. HIRA loss transforms FH-deficient cells. Sci Adv. 2022 Oct 21;8(42):eabq8297. Doi: 10.1126/sciadv.abq8297. PMID: 36269833
Chiorean A, Farncombe KM, Delong S, Andric V, Ansar S, Chan C, Clark K, et al. Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease. Hum Mutat. 2022 Sep;43(9):1268-1285. doi: 10.1002/humu.24392. PMID: 35475554
Baptiste C, Mellis R, Aggarwal V, Lord J, Eberhardt R, Kilby MD, Maher ER, et al. Fetal central nervous system anomalies: When should we offer exome sequencing? Prenat Diagn. 2022 May;42(6):736-743 doi: 10.1002/pd.6145. PMID: 35411553
Andreou A, Yngvadottir B, Bassaganyas L, Clark G, Martin E, Whitworth J, Cornish AJ et al. Elongin C (ELOC/TCEB1)-associated von Hippel-Lindau disease. Hum Mol Genet. 2022 Aug 23;31(16):2728-2737 doi: 10.1093/hmg/ddac066. PMID: 35323939
Annear DJ, Vandeweyer G, Sanchis-Juan A, Raymond FL, Kooy RF. Non-Mendelian inheritance patterns and extreme deviation rates of CGG repeats in autism. Genome Res. 2022 Nov 9:gr.277011.122 doi: 10.1101/gr.277011.122. PMID: 36351771
Jurkute N, Cancellieri F, Pohl L, Li CHZ, Heaton RA, Reurink J, Bellingham J, et al. Biallelic variants in coenzyme Q10 biosynthesis pathway genes cause a retinitis pigmentosa phenotype. NPJ Genom Med. 2022 Oct 20;7(1):60 doi: 10.1038/s41525-022-00330-z. PMID: 36266294
Wolstencroft J, Wicks F, Srinivasan R, Wynn S, Ford T, Baker K, Chawner SJRA, et al. Neuropsychiatric risk in children with intellectual disability of genetic origin: IMAGINE, a UK national cohort study. Lancet Psychiatry. 2022 Sep;9(9):715-724 doi: 10.1016/S2215-0366(22)00207-3. PMID: 35932790
de la Morena-Barrio B, Stephens J, de la Morena-Barrio ME, Stefanucci L, Padilla J, Miñano A, Gleadall N, et al. Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency. Thromb Haemost. 2022 Aug;122(8):1369-1378 doi: 10.1055/s-0042-1749345. PMID: 35764313
Küry S, Zhang J, Besnard T, Caro-Llopis A, Zeng X, Robert SM, Josiah SS, et al. Rare pathogenic variants in WNK3 cause X-linked intellectual disability. Genet Med. 2022 Sep;24(9):1941-1951 doi: 10.1016/j.gim.2022.05.009. PMID: 35678782
Lok A, Fernandez-Garcia MA, Taylor RW, French C, MacFarland R, Bodi I, Champion M, et al. Novel phosphopantothenoylcysteine synthetase (PPCS) mutations with prominent neuromuscular features: Expanding the phenotypical spectrum of PPCS-related disorders. Am J Med Genet A. 2022 Sep;188(9):2783-2789 doi: 10.1002/ajmg.a.62848. PMID: 35616428
Pellegrino B, Herencia-Ropero A, Llop-Guevara A, Pedretti F, Moles-Fernández A, Viaplana C, Villacampa G, et al. Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification. Cancer Res. 2022 Apr 15;82(8):1646-1657 doi: 10.1158/0008-5472.CAN-21-2409. PMID: 35425960
Wong-Spracklen VMY, Kolesnik A, Eck J, Sabanathan S, Spasic-Boskovic O, Maw A, Baker K et al. Biallelic CACNA1A variants: Review of literature and report of a child with drug-resistant epilepsy and developmental delay. Am J Med Genet A. 2022 Nov;188(11):3306-3311 doi: 10.1002/ajmg.a.62960. PMID: 36063114
Hutter T, Collings TS, Kostova G, Karet Frankl FE. Point-of-care and self-testing for potassium: recent advances. Sens Diagn. 2022 Jun 6;1(4):614-626 doi: 10.1039/d2sd00062h. PMID: 35923773
Garcia-Pelaez J, Barbosa-Matos R, Lobo S, Dias A, Garrido L, Castedo S, Sousa S, et al. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. Lancet Oncol. 2022 Nov 24:S1470-2045(22)00643-X doi: 10.1016/S1470-2045(22)00643-X. PMID: 36436516
Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S, Ahmed M, et al. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2. J Med Genet. 2022 Nov 21:jmg-2022-108898 doi: 10.1136/jmg-2022-108898. PMID: 36411032
Li H, Engel C, Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, Radice P, et al. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genet Med. 2022 Oct;24(10):2208 doi: 10.1016/j.gim.2022.08.005. PMID: 34906479
Speight B, Colvin E, Epurescu ED, Drummond J, Verhoef S, Pereira M, Evans DG, Tischkowitz M. Low-level constitutional mosaicism of BRCA1 in two women with young onset ovarian cancer. Hered Cancer Clin Pract. 2022 Sep 6;20(1):32 doi: 10.1186/s13053-022-00237-x. PMID: 36068545
Loong L, Garrett A, Allen S, Choi S, Durkie M, Callaway A, Drummond J, et al. Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK). Genet Med. 2022 Sep;24(9):1867-1877 doi: 10.1016/j.gim.2022.05.002. PMID: 35657381
Miller DE, Lee L, Galey M, Kandhaya-Pillai R, Tischkowitz M, Amalnath D, Vithlani A, et al. Targeted long-read sequencing identifies missing pathogenic variants in unsolved Werner syndrome cases. J Med Genet. 2022 May 9;59(11):1087–94 doi: 10.1136/jmedgenet-2022-108485. PMID: 35534204
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, et al. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. Eur J Hum Genet. 2022 May;30(5):630-631 doi: 10.1038/s41431-022-01085-y. PMID: 35314806
Nyberg T, Tischkowitz M, Antoniou AC. BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis. Br J Cancer. 2022 Apr;126(7):1067-1081 doi: 10.1038/s41416-021-01675-5. PMID: 34963702
Lee A, Yang X, Tyrer J, Gentry-Maharaj A, Ryan A, Mavaddat N, Cunningham AP, et al. Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors. J Med Genet. 2022 Jul;59(7):632-643 doi: 10.1136/jmedgenet-2021-107904. PMID: 34844974
Middleton SJ, Perini I, Themistocleous AC, Weir GA, McCann K, Barry AM, Marshall A, et al. Nav1.7 is required for normal C-low threshold mechanoreceptor function in humans and mice. Brain. 2022 Oct 21;145(10):3637-3653. PMID: 34957475
Randzavola LO, Mortimer PM, Garside E, Dufficy ER, Schejtman A, Roumelioti G, Yu L, et al. EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling. Elife. 2022 Nov 24;11:e76387. PMID: 36421765
Eggermann T, Yapici E, Bliek J, Pereda A, Begemann M, Russo S, et al. Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences. Clin Epigenetics. 2022 Mar 16;14(1):41 doi: 10.1186/s13148-022-01259-x. PMID: 35296332
Brkić D, Ng-Cordell E, O’Brien S, Martin J, Scerif G, Astle D, et al. [Formula: see text]FarmApp: a new assessment of cognitive control and memory for children and young people with neurodevelopmental difficulties. Child Neuropsychol. 2022 Nov;28(8):1097-115 doi: 10.1080/09297049.2022.2054968. PMID: 35332845
Aitken S, Firth HV, Wright CF, Hurles ME, FitzPatrick DR, Semple CA. IMPROVE-DD: Integrating multiple phenotype resources optimizes variant evaluation in genetically determined developmental disorders. HGG Adv. 2023 Jan 12;4(1):100162 doi: 10.1016/j.xhgg.2022.100162. PMID: 36561149